Contraception

A new study finds higher rates of cyanotic congenital heart disease in states with abortion restrictions following the 2022 Supreme Court ruling.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals that combined oral contraceptive use significantly increases the risk of cryptogenic stroke in women aged 18 to 49 years, highlighting the need for careful risk assessment.

In an abstract featured at the 2025 ACOG ACSM, researchers found that after Dobbs, North Carolina saw more out-of-state abortion patients, longer wait times, and increased racial disparities.

A recent study presented at the 2025 ACOG Annual Clinical and Scientific Meeting found that most TikTok videos on hormonal contraception was misleading.

Shared decision making and individualized strategies are emphasized in the new ACOG consensus.

New research presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that mandatory in-person consent and waiting periods in Ohio create significant delays and barriers to abortion access.

New expert guidelines emphasize trauma-informed care and nonpharmacological techniques to reduce pain and improve patient experience during intrauterine device insertion.

A new study reveals significantly increased abortion use among bisexual, lesbian, and mostly heterosexual individuals, underscoring gaps in reproductive health access.

New research links combined oral contraceptives to changes in the gut microbiome that may contribute to mood disorders.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Learn about the intersection of mental health and contraception, with evidence-based guidance on contraceptive options for patients with psychiatric conditions.

Two-thirds of US teen girls live in states with abortion bans, gestational limits, or parental involvement laws, limiting access to care.

While pain is a common deterrent for patients considering an IUD, there are no standardized guidelines for pain relief during insertion or removal.

A recent study presented at the ISSWSH 2025 Annual Meeting found no significant association between hormonal contraceptive use and the severity of clitoral adhesions, though researchers emphasize the need for further investigation.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Learn how clinicians can reduce pain during intrauterine device placement with evidence-based, patient-centered approaches to improve accessibility and patient experience.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent BMJ study reveals that hormonal contraceptives, particularly those containing oestrogen, may elevate the risk of ischemic stroke and heart attack, though absolute risks remain low.

A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reported an increase in US young adults seeking permanent contraception methods following the Supreme Court’s Dobbs v Jackson Women's Health Organization decision in 2022, highlighting the need for accessible contraception.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.

A new study finds that intrauterine instillation of 2% mepivacaine significantly lowers pain levels during intrauterine device placement.